Center for Biological Diversity
EPANonrulemakingEPA-HQ-OPP-2023-0103

EPA and FDA Modernized Approach to Oversight of Certain Products

RIN
Last modified
Mar 21, 2025
Comment window
closed 1191d ago
Center for Biological Diversity filings
2

Activity

Center for Biological Diversity filed 2 comments on this docket between Apr 26, 2023 and May 23, 2023. 15 other organizations filed here. The comment window closed 1191d ago.

What Center for Biological Diversity filed (2)

May 23, 2023· Mass comment campaign submitted by Center for Biological Diversity (18,447 web comments) (petition)· EPA-HQ-OPP-2023-0103-0070

Please see attached the comments from 18,447 Center for Biological Diversity supporters regarding the EPA's current approach to the oversight of various products.

Apr 26, 2023· Comment submitted by Center for Biological Diversity· EPA-HQ-OPP-2023-0103-0065

Please see the attached comments from the Center for Biological Diversity.

Abstract

This is a notice of a public meeting and comment period on a modernized approach to oversight for certain products regulated by EPA and FDA.

View on regulations.gov →
EPA and FDA Modernized Approach to Oversight of Certain Products (EPA) — Center for Biological Diversity | OpenPolis